PRQR · ProQR Therapeutics N.V. · Documents
Market Cap
$182.04M
Shares
141.12M
Volume · Oct 23
1.79M
Avg daily vol (3M)
818.04K
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 6-K | — | 2023-12-08 | — | |
| 6-K | — | 2023-11-07 | 2023-09-30 | |
| 6-K | — | 2023-09-27 | — | |
| 6-K | — | 2023-08-03 | 2023-06-30 | |
| 6-K | — | 2023-08-01 | — | |
| 6-K | — | 2023-05-17 | — | |
| 6-K | — | 2023-05-16 | 2023-03-31 | |
| 6-K | — | 2023-04-18 | — | |
| F-3 | — | 2023-03-29 | — | |
| 20-F | — | 2023-03-29 | 2022-12-31 | |
| 6-K | — | 2023-03-29 | — | |
| 6-K | — | 2023-03-10 | — | |
| 6-K | — | 2022-12-23 | — | |
| 6-K | — | 2022-11-09 | 2022-09-30 | |
| 6-K | — | 2022-09-21 | — | |
| 6-K | — | 2022-08-11 | — | |
| 6-K | — | 2022-08-04 | 2022-06-30 | |
| 6-K | — | 2022-06-30 | — | |
| 6-K | — | 2022-06-01 | — | |
| 6-K | — | 2022-05-05 | 2022-03-31 | |
| 20-F | — | 2022-04-29 | 2021-12-31 | |
| 6-K | — | 2022-04-13 | — | |
| 6-K | — | 2022-04-13 | — | |
| F-3 | — | 2022-03-01 | — | |
| 6-K | — | 2022-02-24 | 2021-12-31 | |
| 6-K | — | 2022-02-11 | — | |
| 6-K | — | 2022-01-04 | — | |
| 6-K | — | 2021-12-30 | — | |
| 6-K | — | 2021-12-16 | — | |
| 6-K | — | 2021-11-18 | — | |
| 6-K | — | 2021-11-18 | — | |
| 6-K | — | 2021-11-04 | 2021-09-30 | |
| F-3 | — | 2021-11-04 | — | |
| F-3 | — | 2021-11-04 | — | |
| 6-K | — | 2021-10-04 | — | |
| 6-K | — | 2021-09-09 | — | |
| 6-K | — | 2021-09-08 | — | |
| 6-K | — | 2021-08-05 | 2021-06-30 | |
| 6-K | — | 2021-07-08 | — | |
| 6-K | — | 2021-05-20 | — | |
| 6-K | — | 2021-05-06 | — | |
| 6-K | — | 2021-05-04 | 2021-05-31 | |
| 6-K | — | 2021-04-20 | — | |
| 6-K | — | 2021-04-06 | — | |
| 6-K | — | 2021-04-01 | — | |
| 6-K | — | 2021-03-24 | — | |
| 6-K | — | 2021-03-24 | — | |
| 20-F | — | 2021-03-24 | 2020-12-31 | |
| 6-K | — | 2021-02-25 | 2020-12-31 | |
| 6-K | — | 2021-01-07 | — |
Showing 51–100 of 113 filings